Alkermes PLC (ALKS)
24.54
-0.34
(-1.37%)
USD |
NASDAQ |
Apr 30, 16:00
24.56
+0.02
(+0.06%)
After-Hours: 20:00
Alkermes Cash from Financing (Quarterly): -276.50M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -276.50M |
| September 30, 2023 | 1.567M |
| June 30, 2023 | 7.836M |
| March 31, 2023 | -22.62M |
| December 31, 2022 | -0.271M |
| September 30, 2022 | -0.212M |
| June 30, 2022 | 14.93M |
| March 31, 2022 | -16.02M |
| December 31, 2021 | -3.179M |
| September 30, 2021 | 1.033M |
| June 30, 2021 | 16.27M |
| March 31, 2021 | 14.94M |
| December 31, 2020 | -0.151M |
| September 30, 2020 | -0.112M |
| June 30, 2020 | 3.016M |
| March 31, 2020 | -4.924M |
| December 31, 2019 | 1.746M |
| September 30, 2019 | 2.906M |
| June 30, 2019 | 1.15M |
| March 31, 2019 | 0.963M |
| December 31, 2018 | -1.989M |
| September 30, 2018 | 0.564M |
| June 30, 2018 | 3.102M |
| March 31, 2018 | -3.297M |
| December 31, 2017 | 4.454M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.143M |
| June 30, 2017 | 5.271M |
| March 31, 2017 | -6.784M |
| December 31, 2016 | -2.541M |
| September 30, 2016 | -55.92M |
| June 30, 2016 | -3.098M |
| March 31, 2016 | 3.387M |
| December 31, 2015 | -1.43M |
| September 30, 2015 | 24.38M |
| June 30, 2015 | 5.975M |
| March 31, 2015 | 11.96M |
| December 31, 2014 | 28.11M |
| September 30, 2014 | 19.36M |
| June 30, 2014 | -3.62M |
| March 31, 2014 | 264.91M |
| September 30, 2013 | 18.41M |
| June 30, 2013 | 12.09M |
| March 31, 2013 | 17.59M |
| December 31, 2012 | 8.58M |
| September 30, 2012 | -68.56M |
| June 30, 2012 | -2.653M |
| March 31, 2012 | 4.57M |
| December 31, 2011 | 0.83M |
| September 30, 2011 | 450.46M |
| June 30, 2011 | 8.986M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-276.50M
Minimum
Dec 2023
16.27M
Maximum
Jun 2021
-13.61M
Average
1.033M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| Endo International PLC | -149.76M |
| Jazz Pharmaceuticals PLC | -100.31M |
| Medtronic PLC | -1.50B |
| Perrigo Co PLC | -44.60M |
| Iterum Therapeutics PLC | 0.589M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 107.24M |
| Cash from Investing (Quarterly) | -20.98M |
| Free Cash Flow | 353.30M |
| Free Cash Flow Per Share (Quarterly) | 0.5405 |
| Free Cash Flow to Equity (Quarterly) | 90.84M |
| Free Cash Flow to Firm (Quarterly) | 90.21M |
| Free Cash Flow Yield | 8.53% |